Comparisons & the verdict

Where epitalon sits, and how to read it going forward

The final teaching unit puts epitalon in context: against other telomerase-related interventions like TA-65 and astragaloside compounds, against the evidence hierarchy, and against the telomere-function disconnect that the best-tested activator in the category ran into. It ends with a toolkit for spotting overclaims so the literacy outlasts the course.

The verdict is not "useless" and not "proven." It is a legitimate research peptide whose marketing has run well ahead of its evidence, which is exactly the nuance worth carrying out the door.